Escientia Advanced Sciences Profile
Key Indicators
- Authorised Capital ₹ 22.00 Cr
as on 28-07-2024
- Paid Up Capital ₹ 21.49 Cr
as on 28-07-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 165.00 Cr
as on 28-07-2024
- Satisfied Charges ₹ 20.00 Cr
as on 28-07-2024
- Revenue -28.91%
(FY 2023)
- Profit -50.75%
(FY 2023)
- Ebitda -22.67%
(FY 2023)
- Net Worth 24.86%
(FY 2023)
- Total Assets 62.16%
(FY 2023)
About Escientia Advanced Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 22.00 Cr and a paid-up capital of Rs 21.49 Cr.
The company currently has active open charges totaling ₹165.00 Cr. The company has closed loans amounting to ₹20.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Escientia Advanced Sciences Private Limited India is Srinivasa Korada as CFO. Yadagiri Pendri, Pendri Reddy, Dandu Chakradhar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2013PTC085962
- Company No.
085962
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 2013
- Date of AGM
12 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Shameerpet, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Escientia Advanced Sciences?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Srinivasa Korada | CFO | 01-Mar-2021 | Current |
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vivek Save | Director | 19-Aug-2020 | Current |
Pendri Reddy | Director | 27-Feb-2013 | Current |
Yadagiri Pendri | Director | 27-Feb-2013 | Current |
Dandu Chakradhar | Director | 19-Aug-2020 | Current |
Ajit George | Director | 24-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Escientia Advanced Sciences.
Escientia Advanced Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.91% decrease. The company also saw a substantial fall in profitability, with a 50.75% decrease in profit. The company's net worth Soared by an impressive increase of 24.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Escientia Advanced Sciences?
In 2023, Escientia Advanced Sciences had a promoter holding of 0.05% and a public holding of 99.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Escientia Biopharma Private LimitedActive 16 years 10 months
Yadagiri Pendri, Pendri Reddy and 3 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 29 Jun 2021 | ₹65.00 Cr | Open |
Others Creation Date: 02 Nov 2020 | ₹100.00 Cr | Open |
Others Creation Date: 02 Nov 2020 | ₹20.00 Cr | Satisfied |
How Many Employees Work at Escientia Advanced Sciences?
Escientia Advanced Sciences has a workforce of 295 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Escientia Advanced Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Escientia Advanced Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.